“Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial”, J of Skin, vol. 3, p. S9, Nov. 2019, doi: 10.25251/skin.3.supp.9.